MEDS vs. COSM, BIMI, VAPO, INBS, UPC, LIXT, OPGN, ASLN, IMCC, and BFRI
Should you be buying TRxADE HEALTH stock or one of its competitors? The main competitors of TRxADE HEALTH include Cosmos Health (COSM), BIMI (BIMI), Vapotherm (VAPO), Intelligent Bio Solutions (INBS), Universe Pharmaceuticals (UPC), Lixte Biotechnology (LIXT), OpGen (OPGN), ASLAN Pharmaceuticals (ASLN), IM Cannabis (IMCC), and Biofrontera (BFRI). These companies are all part of the "medical" sector.
Cosmos Health (NASDAQ:COSM) and TRxADE HEALTH (NASDAQ:MEDS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability, media sentiment and community ranking.
In the previous week, Cosmos Health had 13 more articles in the media than TRxADE HEALTH. MarketBeat recorded 16 mentions for Cosmos Health and 3 mentions for TRxADE HEALTH. TRxADE HEALTH's average media sentiment score of 0.26 beat Cosmos Health's score of -0.04 indicating that Cosmos Health is being referred to more favorably in the media.
TRxADE HEALTH has lower revenue, but higher earnings than Cosmos Health.
Cosmos Health has a net margin of -31.48% compared to Cosmos Health's net margin of -78.18%. TRxADE HEALTH's return on equity of -28.54% beat Cosmos Health's return on equity.
Cosmos Health has a beta of 5.97, meaning that its share price is 497% more volatile than the S&P 500. Comparatively, TRxADE HEALTH has a beta of 2.01, meaning that its share price is 101% more volatile than the S&P 500.
12.6% of Cosmos Health shares are owned by institutional investors. Comparatively, 5.7% of TRxADE HEALTH shares are owned by institutional investors. 18.7% of Cosmos Health shares are owned by insiders. Comparatively, 48.4% of TRxADE HEALTH shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Cosmos Health received 20 more outperform votes than TRxADE HEALTH when rated by MarketBeat users. Likewise, 70.69% of users gave Cosmos Health an outperform vote while only 52.50% of users gave TRxADE HEALTH an outperform vote.
Summary
Cosmos Health beats TRxADE HEALTH on 11 of the 14 factors compared between the two stocks.
Get TRxADE HEALTH News Delivered to You Automatically
Sign up to receive the latest news and ratings for MEDS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MEDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
TRxADE HEALTH Competitors List
Related Companies and Tools
